Fingerprint
Dive into the research topics of 'Combination of the mTOR inhibitor rapamycin and CC-5013 has synergistic activity in multiple myeloma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Combination of the mTOR inhibitor rapamycin and CC-5013 has synergistic activity in multiple myeloma
Noopur Raje, Shaji Kumar, Teru Hideshima, Kenji Ishitsuka, Dharminder Chauhan, Constantine Mitsiades, Klaus Podar, Steven Le Gouill, Paul Richardson, Nikhil C. Munshi, David I. Stirling, Joseph H. Antin, Kenneth C. Anderson
Research output: Contribution to journal › Article › peer-review
173
Scopus
citations